10/27/2025
                                            More than 11 million people around the world are living with Parkinson’s disease, and the condition is the fastest growing age-related neurological disease. Parkinson’s causes tremor – uncontrollable shaking – as well as stiffness, slowness and difficulty moving. Despite decades of research, no way has been found to stop this nerve degeneration.
This week, a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration for the first novel treatment for Parkinson’s disease in more than half a century. Tavapadon's potential as a new treatment for Parkinson’s and other disorders was pioneered by School of Medicine at the University of Virginia Professor of Pharmacology and Neuroscience Richard B. Mailman, PhD.
💊 Learn more at https://bit.ly/4ojbA8A